Pioneering diagnostics

Clinical diagnostics applications

In vitro diagnostics are an essential link in the healthcare chain, supporting medical decisions and contributing to the control of healthcare spending.

In vitro diagnostic tests are extremely useful to healthcare
professionals for:


  • screening for diseases,
  • diagnosis,
  • prognosis,
  • referrals and follow-up treatment.




Between 60% and 70% of medical decisions are based upon in vitro diagnostic tests

The increasing importance of diagnostics

In vitro diagnostics contribute to medical decision-making.

Initially used to identify diseases, in vitro diagnostic tools are increasingly being used to:

  • personalize patient management,
  • indicate the most appropriate treatment,
  • reduce side effects as much as possible,
  • reduce healthcare spending.

In vitro diagnostics account for only 2% to 3% of healthcare spending

bioMérieux's product offering

  • With 50 years of experience in the field of in vitro diagnostics, bioMérieux has contributed to the technological transformations in the field, enabling us to offer a range of increasingly sophisticated tools.
  • Our solutions are primarily intended for the diagnosis of infectious diseases and cardiovascular emergencies, as well as screening and monitoring of cancers. We also offer diagnostic tests for metabolic, allergy-related and hormonal pathologies.

Infectious diseases

Diagnostic solutions

  • Infections (urinary tract infections, septicemia): detection and identification of the bacterium responsible and selection of appropriate antibiotic treatment.
  • Heathcare-associated (nosocomial) infections: detection and monitoring.
  • Viral infections such as HIV, hepatitis, rubella, infectious mononucleosis, etc.: diagnosis and monitoring.

Cardiovascular emergencies

High medical-value tests

  • Heart attack: the diagnostic test detects cardiac markers, indicating the destruction of myocardial cells.
  • Venous thrombosis (phlebitis in one of the lower limbs, which can develop and become a pulmonary embolism): biological diagnostic tests detect substances (metabolites) released when the clot is formed.


Screening and monitoring tests

  • A cancer is a proliferation of abnormal cells. Such cells carry unusual antigens on their surface or release abnormal substances into the blood: these are known as tumor markers.
  • Detecting and quantifying these tumor markers form part of the screening and monitoring process for many cancers.